Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
NCT06626243 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140
Last updated 2024-11-29
Summary
The study is a retrospective observational study. The study is designed to be multicentric and international and it will analyze medical records from selected patients diagnosed with locally advanced and resectable NSCLC who underwent lung resection by robotic, VATS and open approach after receiving neoadjuvant chemo-immunotherapy.
There are no risks for the patients, as this is a retrospective data collection.
Conditions
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
collaborator OTHER -
Istituto Clinico Humanitas
collaborator OTHER -
Regina Elena Cancer Institute
collaborator OTHER -
Baptist Health South Florida
collaborator OTHER -
West Virginia University
collaborator OTHER -
Scientific Institute San Raffaele
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-30
- Primary Completion
- 2025-02-15
- Completion
- 2025-10-15
Countries
- United States
- Italy
Study Locations
More Related Trials
-
Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients
NCT04205552 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Chemo for Non-metastatic Non-small Cell Lung Cancer
NCT01860040 ·Status: TERMINATED ·Phase: PHASE2
-
Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
NCT01486602 ·Status: COMPLETED ·Phase: PHASE1
-
Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer
NCT04379739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Reduced CT + Anti-PD-1 as First Line Tx in Vulnerable Older Adults w/Adv <50% PD-L1 Non-Small Cell Lung Cancer (NSCLC)
NCT06731413 ·Status: RECRUITING ·Phase: PHASE2
-
Chemo-immunotherapy, Hypo-fractionated RT and Maintenance Immunotherapy for Stage III NSCLC.
NCT05128630 ·Status: RECRUITING ·Phase: PHASE2
-
Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
NCT03237377 ·Status: TERMINATED ·Phase: PHASE2
-
NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy
NCT00535275 ·Status: TERMINATED ·Phase: PHASE3
-
Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001
NCT03574818 ·Status: TERMINATED ·Phase: PHASE2
-
ICIs Neoadjuvant Therapy in Resectable Non-Small-Cell Lung Cancer
NCT03732664 ·Status: COMPLETED ·Phase: PHASE1
-
Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer
NCT03603002 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
NCT05061550 ·Status: RECRUITING ·Phase: PHASE2
-
A Randomized Phase II Study of SUBATM-itraconazole in Patients With Untreated Squamous NSCLC.
NCT01752023 ·Status: TERMINATED ·Phase: PHASE2
-
Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer
NCT00003159 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
NCT06987734 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
NCT00863512 ·Status: TERMINATED ·Phase: PHASE3
-
Real-World Study on Adjuvant Therapy Combined With Shenlingcao Oral Liquid in Patients for Stage II and IIIA Non-small Cell Lung Cancer After Radical Resection
NCT03479294 ·Status: TERMINATED
-
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
NCT04697446 ·Status: UNKNOWN
-
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
NCT06632327 ·Status: RECRUITING ·Phase: PHASE3
-
Iparomlimab and Tuvonralimab Combined With 2 or 4 Cycles of Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC
NCT07129161 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost
NCT06627738 ·Status: RECRUITING ·Phase: PHASE2
-
Individualized Chemotherapy Based on BRCA1 and RRM1 mRNA for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT01424709 ·Status: UNKNOWN ·Phase: PHASE2
-
Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy
NCT00256841 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy
NCT00864331 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
NCT04832854 ·Status: TERMINATED ·Phase: PHASE2